0001567619-20-001243.txt : 20200117 0001567619-20-001243.hdr.sgml : 20200117 20200117163035 ACCESSION NUMBER: 0001567619-20-001243 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200117 DATE AS OF CHANGE: 20200117 EFFECTIVENESS DATE: 20200117 FILER: COMPANY DATA: COMPANY CONFORMED NAME: vTv Therapeutics Inc. CENTRAL INDEX KEY: 0001641489 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473916571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-358461 FILM NUMBER: 20533949 BUSINESS ADDRESS: STREET 1: 3980 PREMIER DR STREET 2: SUITE 310 CITY: HIGH POINT STATE: NC ZIP: 27265 BUSINESS PHONE: 336-841-0300 MAIL ADDRESS: STREET 1: 3980 PREMIER DR STREET 2: SUITE 310 CITY: HIGH POINT STATE: NC ZIP: 27265 FORMER COMPANY: FORMER CONFORMED NAME: VTV Therapeutics Inc. DATE OF NAME CHANGE: 20150506 D 1 primary_doc.xml X0708 D LIVE 0001641489 vTv Therapeutics Inc. 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 336-841-0300 DELAWARE None VTV Therapeutics Inc. Corporation true 2015 Stephen Holcombe 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Executive Officer Rudy Howard 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Executive Officer Jeffrey Kindler 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director Hersh Kozlov 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director John Fry 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director Paul Savas 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director Noel Spiegel 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director Howard Weiner 3980 Premier Drive Suite 310 High Point NC NORTH CAROLINA 27265 Director Pharmaceuticals Decline to Disclose 06b false 2020-01-07 false true true false 0 10000000 2000000 8000000 See the Issuer's Current Reports on Form 8-K filed with the Securities and Exchange Commission on December 23, 2019 and January 7, 2020. false 0 0 0 0 false vTv Therapeutics Inc. /s/ Rudy C. Howard Rudy C. Howard Chief Financial Officer 2020-01-17